EPRX – eupraxia pharmaceuticals inc. (US:NASDAQ)

News

Eupraxia Pharmaceuticals (EPRX) was upgraded by Wall Street Zen from
Eupraxia Pharmaceuticals to Present at Upcoming Investor Conferences [Canadian Business Journal (Canada)]
Eupraxia Pharmaceuticals to Present at Upcoming Investor Conferences
Eupraxia Pharmaceuticals (EPRX) is now covered by William Blair. They set an "outperform" rating on the stock.
Eupraxia Pharmaceuticals (EPRX) was downgraded by Zacks Research from "hold" to "strong sell".
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com